LifeStance Health Group (NASDAQ:LFST) Downgraded to “Hold” Rating by Zacks Research

LifeStance Health Group (NASDAQ:LFST) was downgraded by Zacks Research from a “strong-buy” rating to a “hold” rating in a report issued on Monday,Zacks.com reports.

A number of other research analysts have also commented on the company. Barclays increased their price objective on LifeStance Health Group from $9.00 to $13.00 and gave the company an “overweight” rating in a research report on Tuesday. JPMorgan Chase & Co. increased their target price on shares of LifeStance Health Group from $8.00 to $9.00 and gave the stock a “neutral” rating in a report on Thursday, May 14th. KeyCorp raised their price target on LifeStance Health Group from $11.00 to $13.00 and gave the stock an “overweight” rating in a research report on Monday. Wall Street Zen raised shares of LifeStance Health Group from a “buy” rating to a “strong-buy” rating in a research report on Saturday, July 4th. Finally, BTIG Research upped their price target on LifeStance Health Group from $11.00 to $12.00 and gave the stock a “buy” rating in a research report on Friday, May 8th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, LifeStance Health Group currently has an average rating of “Moderate Buy” and an average price target of $10.75.

LifeStance Health Group Trading Down 0.8%

Shares of LFST stock opened at $10.79 on Monday. LifeStance Health Group has a 12-month low of $3.74 and a 12-month high of $11.62. The firm has a 50-day moving average price of $8.81 and a 200 day moving average price of $7.59. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 0.18. The company has a market capitalization of $4.18 billion, a P/E ratio of 179.83 and a beta of 1.12.

LifeStance Health Group (NASDAQ:LFST) last announced its earnings results on Wednesday, May 6th. The company reported $0.04 EPS for the quarter, topping the consensus estimate of $0.01 by $0.03. The business had revenue of $403.48 million for the quarter, compared to the consensus estimate of $387.46 million. LifeStance Health Group had a return on equity of 1.56% and a net margin of 1.55%.LifeStance Health Group’s revenue was up 21.2% compared to the same quarter last year. Research analysts forecast that LifeStance Health Group will post 0.12 earnings per share for the current fiscal year.

Insider Activity

In other LifeStance Health Group news, Director Robert Bessler sold 894,337 shares of the stock in a transaction dated Friday, June 26th. The shares were sold at an average price of $10.13, for a total transaction of $9,059,633.81. Following the sale, the director directly owned 539,763 shares in the company, valued at $5,467,799.19. This represents a 62.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Darren M. Black sold 5,899,661 shares of the stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $8.02, for a total transaction of $47,315,281.22. Following the sale, the director owned 23,310,115 shares in the company, valued at $186,947,122.30. This represents a 20.20% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 7,762,394 shares of company stock worth $64,107,859. Corporate insiders own 3.50% of the company’s stock.

Institutional Trading of LifeStance Health Group

Several large investors have recently bought and sold shares of LFST. Assetmark Inc. grew its position in LifeStance Health Group by 17.0% during the 1st quarter. Assetmark Inc. now owns 9,419 shares of the company’s stock worth $60,000 after acquiring an additional 1,367 shares during the last quarter. Park Edge Advisors LLC lifted its position in shares of LifeStance Health Group by 14.4% in the 4th quarter. Park Edge Advisors LLC now owns 11,863 shares of the company’s stock worth $84,000 after purchasing an additional 1,495 shares during the period. California State Teachers Retirement System boosted its position in LifeStance Health Group by 1.6% during the fourth quarter. California State Teachers Retirement System now owns 125,682 shares of the company’s stock valued at $885,000 after acquiring an additional 1,966 shares during the last quarter. Vident Advisory LLC boosted its position in shares of LifeStance Health Group by 12.7% during the 2nd quarter. Vident Advisory LLC now owns 21,732 shares of the company’s stock valued at $112,000 after purchasing an additional 2,447 shares in the last quarter. Finally, Xponance LLC grew its position in shares of LifeStance Health Group by 26.4% during the 4th quarter. Xponance LLC now owns 13,144 shares of the company’s stock worth $93,000 after buying an additional 2,745 shares during the period. 85.50% of the stock is owned by institutional investors and hedge funds.

LifeStance Health Group Company Profile

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.